Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 83
Filter
1.
BMJ Case Rep ; 13(9)2020 Sep 09.
Article in English | MEDLINE | ID: mdl-32912882

ABSTRACT

We report the case of a pituitary stalk germinoma initially misdiagnosed and treated as infundibuloneurohypophysitis (INH). A 27-year-old man presented with a 1-year history of polydipsia, polyuria, nycturia consistent with central diabetes insipidus and a hyperintense pituitary stalk lesion on MRI. A possible INH diagnosis was considered, after excluding other pathologies. Lesion biopsy was discarded at that time on the ground of a small target and the high risk of added morbidity. Oral desmopressin led to initial symptoms resolution but, in the following months, an anterior panhypopituitarism developed, in spite of appropriate treatment and, by that time, the brain MRI also revealed lesion growth, which prompted a biopsy recommendation. The pathology analysis revealed a germinoma. After chemotherapy and radiotherapy, there was complete disappearance of the pituitary lesion, but the panhypopituitarism persisted. In conclusion, this case highlights the importance and difficulty of precise diagnosis in the initial assessment of pituitary stalk lesions and the need for close monitoring of treatment response. Diagnostic reassessment and biopsy in atypical cases is the only path to achieve the correct diagnosis and treatment.


Subject(s)
Chemoradiotherapy/methods , Deamino Arginine Vasopressin/administration & dosage , Diabetes Insipidus, Neurogenic , Germinoma , Hydrocortisone/administration & dosage , Hypopituitarism , Pituitary Gland , Pituitary Neoplasms , Thyroxine/administration & dosage , Adult , Autoimmune Hypophysitis/diagnosis , Biopsy/methods , Diabetes Insipidus, Neurogenic/diagnosis , Diabetes Insipidus, Neurogenic/drug therapy , Diabetes Insipidus, Neurogenic/etiology , Diagnosis, Differential , Drug Monitoring/methods , Germinoma/pathology , Germinoma/physiopathology , Germinoma/therapy , Hormone Replacement Therapy/methods , Hormones/administration & dosage , Humans , Hypopituitarism/diagnosis , Hypopituitarism/etiology , Hypopituitarism/physiopathology , Magnetic Resonance Imaging/methods , Male , Pituitary Gland/diagnostic imaging , Pituitary Gland/pathology , Pituitary Neoplasms/pathology , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/therapy , Treatment Outcome
2.
Pediatr Blood Cancer ; 64(10)2017 Oct.
Article in English | MEDLINE | ID: mdl-28436607

ABSTRACT

OBJECTIVE: Patients with brain tumors often report having visual complaints. This may be due to increased intracranial pressure, compression/invasion of the optic pathway or diplopia. We assessed the incidence and the etiology of visual symptoms in patients with intracranial germinoma tumors (ICGTs). METHODS AND MATERIALS: We performed a blinded retrospective review of the clinical charts and the initial magnetic resonance imaging (MRI) of 28 patients with ICGT. Thirteen tumors were pineal, five suprasellar, seven bifocal, and further three involved either the optic nerve, the corpus callosum, or the brainstem. RESULTS: Twelve patients reported visual disturbances, seven of whom mainly experienced a decrease in vision. Two of those were initially managed as "retrobulbar neuritis" when endocrinologic symptoms prompted assessment by MRI. Involvement of the optic pathway was underestimated, and both relapsed. Field deficits were definitive sequelae, whereas visual acuity was sometimes regressive in the absence of optic atrophy. CONCLUSIONS: Compression or invasion of the optic pathway by germinomas is not a rare occurrence, and this possibility should not be overlooked when thickening or contrast enhancement is detected. Radiotherapy fields should be extended accordingly.


Subject(s)
Brain Neoplasms , Diplopia , Germinoma , Magnetic Resonance Imaging , Nerve Compression Syndromes , Optic Nerve Diseases , Adolescent , Adult , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/epidemiology , Brain Neoplasms/physiopathology , Child , Diplopia/diagnostic imaging , Diplopia/epidemiology , Diplopia/physiopathology , Female , Germinoma/diagnostic imaging , Germinoma/epidemiology , Germinoma/physiopathology , Humans , Intracranial Pressure , Male , Nerve Compression Syndromes/diagnostic imaging , Nerve Compression Syndromes/epidemiology , Nerve Compression Syndromes/physiopathology , Optic Nerve/diagnostic imaging , Optic Nerve/physiopathology , Optic Nerve Diseases/diagnostic imaging , Optic Nerve Diseases/epidemiology , Optic Nerve Diseases/physiopathology , Retrospective Studies
3.
J Clin Immunol ; 34(8): 922-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25216720

ABSTRACT

Interferon-γ receptor 1 (IFN-γR1) deficiency is one of the primary immunodeficiencies conferring Mendelian Susceptibility to Mycobacterial Disease (MSMD). Some cases of neoplasms have been recently reported in patients with MSMD, underlying the already known link between immunodeficiency and carcinogenesis. We report the first case of intracranial tumour, i.e. pineal germinoma, in a 11-year-old patient with complete IFN-γR1 deficiency. The first clinical presentation of the genetic immunodeficiency dates back to when the child was aged 2 y and 10 mo, when he presented a multi-focal osteomyelitis caused by Mycobacterium scrofulaceum. The diagnosis of IFN-γR1 deficiency (523delT/523delT in IFNGR1 gene) was subsequently made. The child responded to antibiotic therapy and remained in stable clinical condition until the age of 11 years, when he started complaining of frontal, chronic headache. MRI revealed a solid pineal region mass lesion measuring 20 × 29 × 36 mm. Histological findings revealed a diagnosis of pineal germinoma. The patient received chemotherapy followed by local whole ventricular irradiation with boost on pineal site, experiencing complete remission, and to date he is tumor-free at four years follow-up. Four other cases of tumors have been reported in patients affected by MSMD in our knowledge: a case of Kaposi sarcoma, a case of B-cell lymphoma, a case of cutaneous squamous cell carcinoma and a case of oesophageal squamous cell carcinoma. In conclusion, in patients with MSMD, not only the surveillance of infectious diseases, but also that of tumors is important.


Subject(s)
Antineoplastic Agents/therapeutic use , Germinoma/complications , Germinoma/therapy , Immunologic Deficiency Syndromes/complications , Immunologic Deficiency Syndromes/genetics , Radiotherapy , Receptors, Interferon/genetics , Age of Onset , Child , Germinoma/physiopathology , Humans , Male , Pineal Gland/pathology , Receptors, Interferon/deficiency , Treatment Outcome , Interferon gamma Receptor
5.
J Pediatr Endocrinol Metab ; 25(5-6): 499-502, 2012.
Article in English | MEDLINE | ID: mdl-22876545

ABSTRACT

AIM: The aim of this study is to evaluate the clinical, anthropometric, hormonal, and radiological characteristics of children with central diabetes insipidus (DI). METHODS: Case records of 34 children (22 boys and 12 girls) with documented central DI referred to the Pediatric Endocrinology and Adolescent Clinic of Dokuz Eylul University Faculty of Medicine were reviewed. The mean age at diagnosis was 6.4 +/- 5.6 years (range, 0.08-16 years). All patients underwent anterior pituitary function assessment and magnetic resonance imaging of pituitary at diagnosis. The median duration of follow-up was 7.9 +/- 4.5 years. RESULTS: The etiology of central DI was organic in 22 (64.7%) patients, trauma in 2 (5.9%) patients, and idiopathic in 10 (29.4%) patients. Organic causes consisted of craniopharyngioma in 7 patients, Langerhans cell histiocytosis in 4 patients, germinoma in 4 patients, holoprosencephaly in 3 patients, astrocytoma in 1 patient, cavernous hemangioma in 1 patient, Rathke's cleft cyst in 1 patient, and autoimmune polyendocrinopathy in 1 patient. Anterior pituitary hormone deficiencies were documented in 18 (53%) patients. Organic central DI group had a greater prevalence of anterior pituitary hormone deficiency when compared with the idiopathic group (66% and 10%, respectively; p = 0.007). The final height of patients with organic etiology were significantly lower than the idiopathic group (155 and 178, cm respectively; p = 0.021). CONCLUSIONS: Etiological diagnosis is possible in a significant proportion (70.6%) of children with central DI. Findings of this study suggest that accompanying anterior pituitary hormone deficiencies and short stature may be considered as indicators of organic etiology.


Subject(s)
Craniocerebral Trauma/complications , Craniopharyngioma/complications , Diabetes Insipidus, Neurogenic/etiology , Diabetes Insipidus, Neurogenic/physiopathology , Pituitary Gland, Anterior/physiopathology , Pituitary Neoplasms/complications , Adolescent , Astrocytoma/complications , Astrocytoma/physiopathology , Brain Neoplasms/complications , Brain Neoplasms/physiopathology , Child , Child, Preschool , Craniocerebral Trauma/physiopathology , Craniopharyngioma/physiopathology , Female , Follow-Up Studies , Germinoma/complications , Germinoma/physiopathology , Histiocytosis, Langerhans-Cell/complications , Histiocytosis, Langerhans-Cell/physiopathology , Holoprosencephaly/complications , Holoprosencephaly/physiopathology , Humans , Infant , Male , Pituitary Neoplasms/physiopathology , Retrospective Studies , Turkey
6.
Chin Med J (Engl) ; 125(15): 2790-3, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22931997

ABSTRACT

Intracranial germinomas are malignant neoplasms of gonadal origin, which have some features in terms of age, sex, and clinical manifestations. They mainly occur in children and adolescents. Patients with intracranial germinomas mainly manifest with hypothalamic pituitary axis dysfunction and/or compression syndromes. Visual disturbance is one of the most significant clinical presentations, which is mainly caused by tumor cell infiltration into the optic pathway. In this article, we present three cases of patient with intracranial germinoma to analyze the ocular manifestations. All the three patients presented with endocrine symptoms in the early stage and with visual disturbances (including decreased visual acuity and visual field defects) later. In general, germinoma is diagnosed by its characteristic radiological appearance, supported by tumor markers and/or stereotactic biopsy. However, decisive diagnoses were established when ocular manifestations were presented. A suspicion for germinoma should be considered, when young patients manifest visual disturbances accompanied by endocrine symptoms.


Subject(s)
Brain Neoplasms/diagnosis , Brain Neoplasms/physiopathology , Germinoma/diagnosis , Germinoma/physiopathology , Vision Disorders/physiopathology , Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult
7.
J Clin Neurosci ; 19(5): 769-71, 2012 May.
Article in English | MEDLINE | ID: mdl-22321364

ABSTRACT

Germinoma mainly occurs in the pituitary stalk, pineal region, and basal ganglia. Sex predominance of the tumor in males in the pineal region and basal ganglia is well known. Primary germinoma of the medulla oblongata is rare, with only eight reports, mostly in females. We report the second male patient with primary medulla oblongata germinoma, without chromosomal abnormality, who was successfully treated with surgery, chemotherapy, and radiotherapy.


Subject(s)
Antineoplastic Protocols/standards , Brain Stem Neoplasms/pathology , Brain Stem Neoplasms/therapy , Germinoma/pathology , Germinoma/therapy , Medulla Oblongata/pathology , Adult , Brain Stem Neoplasms/physiopathology , Germinoma/physiopathology , Humans , Male , Medulla Oblongata/physiopathology , Medulla Oblongata/surgery , Somatosensory Disorders/etiology
8.
Neurol Med Chir (Tokyo) ; 51(2): 148-52, 2011.
Article in English | MEDLINE | ID: mdl-21358162

ABSTRACT

Two boys aged 8 and 12 years presented with intracranial germinoma manifesting as cerebral hemispheric atrophy, hemiparesis, and decline in academic performance. First magnetic resonance (MR) imaging showed no enhanced lesions, but follow-up MR imaging obtained 12 or 23 months after the first visit showed new mass lesions in the temporal lobe or pituitary gland. Biopsy of these lesions resulted in a histological diagnosis of germinoma. Chemoradiation therapy produced complete remission but both patients continued to manifest mild hemiparesis and impaired cognitive function. Review of 18 previous and our 2 patients presenting with hemispheric atrophy revealed strong male predominance (18:2), mean age of 12.8 ± 5.2 (standard deviation) years, hemiparesis in all patients, and cognitive decline in 9 patients. Initial MR imaging detected mass lesions in only 9 patients, but follow-up MR imaging performed 10-38 months later detected new mass lesions in 5 patients. Radiation with/without chemotherapy provided good tumor control in all patients, but none of the 9 patients with cognitive dysfunction recovered their intellectual ability. We recommend early diagnosis based on biopsy of the atrophic site and timely treatment to improve the quality of life in these patients.


Subject(s)
Brain Neoplasms/pathology , Brain/pathology , Germinoma/pathology , Pituitary Neoplasms/pathology , Atrophy , Brain Neoplasms/physiopathology , Brain Neoplasms/therapy , Child , Follow-Up Studies , Germinoma/physiopathology , Germinoma/therapy , Humans , Male , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/therapy
10.
Eur Urol ; 58(1): 134-40, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20395037

ABSTRACT

BACKGROUND: Preserved fertility is an important issue for testicular cancer (TC) survivors. OBJECTIVE: Our aim was to examine any difference regarding paternity and testicular function following two, three, or four cycles of cisplatin-based chemotherapy for TC. DESIGN, SETTING, AND PARTICIPANTS: A national multicentre follow-up survey assessing morbidity among survivors of unilateral TC diagnosed from 1980 to 1994 was conducted during the period 1998 to 2002. Of the 1814 men invited, 1462 (80.6%) participated by responding to a mailed questionnaire and/or undergoing a clinical examination including laboratory assessments. The present study includes the 316 participants up to 65 yr of age treated with two to four cycles of standard cisplatin-based chemotherapy without additional treatment beyond surgery. MEASUREMENTS: Self-reported paternity following treatment for TC according to number of cycles was assessed among men who reported antegrade ejaculation and attempts at posttreatment conception (n=106). Kaplan-Meier analysis, log-rank test, and Cox regression were applied. Gonadal hormones (n=305-314) and sperm counts (n=71) by number of cycles were assessed by linear by linear association or Mann-Whitney tests. RESULTS AND LIMITATIONS: At median 12-yr follow-up, 80% (85 of 106) had succeeded in their attempts of achieving posttreatment paternity (two cycles: 100%; three: 83%; four: 76%; p=0.022). For all patients the 15-yr actuarial paternity rate was 85%. The association between posttreatment paternity and number of cycles remained significant in the multivariate analysis (p=0.032). High serum follicle-stimulating hormone values were more common with increasing number of cycles (p=0.037), but there were no differences in serum luteinising hormone, serum testosterone, or sperm counts. Few men treated with two cycles and a limited number of sperm samples are the main limitations of this study. CONCLUSIONS: The prospects of future paternity after two to four cycles of cisplatin-based chemotherapy are good, and our data suggest that the prospects improve with decreasing number of cycles.


Subject(s)
Antineoplastic Agents/therapeutic use , Cisplatin/therapeutic use , Germinoma/drug therapy , Paternity , Survivors/statistics & numerical data , Testicular Neoplasms/drug therapy , Testicular Neoplasms/physiopathology , Testis/physiology , Adult , Antineoplastic Agents/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cisplatin/adverse effects , Ejaculation/drug effects , Fertilization/drug effects , Follicle Stimulating Hormone/blood , Follow-Up Studies , Germinoma/physiopathology , Germinoma/surgery , Health Surveys/statistics & numerical data , Humans , Infertility, Male/chemically induced , Luteinizing Hormone/blood , Male , Middle Aged , Multicenter Studies as Topic , Orchiectomy , Sperm Count/statistics & numerical data , Testicular Neoplasms/surgery , Testosterone/blood , Young Adult
12.
Prog Neurol Surg ; 23: 130-139, 2009.
Article in English | MEDLINE | ID: mdl-19329867

ABSTRACT

PURPOSE: To assess the quality of life (QOL) of extremely long-time survivors with germinoma mainly treated with radiotherapy. PATIENTS AND METHODS: We enrolled 52 of 68 patients who received radiotherapy between 1968 and 1995 at our hospital. They were 41 males and 11 females; the tumor location was pineal in 20, neurohypophyseal in 15, pineal and neurohypophyseal in 11 patients; in 6 it was located in another region. All underwent radiotherapy; the median dose was 48.2 (range 40.0-60.2) Gy. The median follow-up period was 226 (range 0-448) months. The clinical outcome and QOL were evaluated retrospectively. RESULTS: In 6 patients, the tumor recurred; 6 other patients developed second tumors while in complete remission from the first tumor. The main cause of 12 deaths was complications due to primary tumor invasion, the initial treatment, or tumor recurrence rather than tumor progression. The 10-, 20-, and 30-year actuarial survival rate was 83.6, 77.5, and 64.2%, respectively. Of 44 patients, 6 were married and 3 males with solitary pineal tumors were fathers. Among 32 patients, 14 had, or had not, graduated from high school; the other 18 went on to higher education. Twenty-one patients had no occupation; 7 of 11 formerly employed patients had left their jobs. CONCLUSION: Radiotherapy delivered between 1968 and 1995 to patients with germinoma yielded satisfactory outcomes but a decline in the QOL.


Subject(s)
Brain Neoplasms/radiotherapy , Germinoma/radiotherapy , Pineal Gland , Pinealoma/radiotherapy , Quality of Life , Adolescent , Adult , Brain Neoplasms/mortality , Brain Neoplasms/physiopathology , Child , Disease-Free Survival , Female , Follow-Up Studies , Germinoma/mortality , Germinoma/physiopathology , Humans , Male , Neoplasm Recurrence, Local/mortality , Pinealoma/mortality , Pinealoma/physiopathology , Retrospective Studies , Survival Rate , Treatment Outcome , Young Adult
13.
Arch. esp. urol. (Ed. impr.) ; 61(5): 626-630, jun. 2008. ilus, tab
Article in Es | IBECS | ID: ibc-65664

ABSTRACT

Objetivos: La existencia de tumores mixtos germinales no seminomatosos es un hecho frecuente en patología oncológica urológica. Sin embargo, la presencia de componente seminomatoso y no seminomatoso en un tumor germinal es una situación infrecuente. Métodos: Presentamos un caso de un seminoma puro testicular con metástasis ganglionar por carcinoma embrionario puro con un completo estudio inmunohistoquímico diferencial y evolución clínica del paciente. Resultados: Este caso corresponde a un varón de 34 años que acude a urgencias por notar una tumoración supraclavicular de 3 cm. En TAC de control se detecta adenopatías múltiples de gran tamaño a nivel supraclavicular y retroperitoneal con metástasis (M+) numerosas a nivel pulmonar, renal, hepática y suprarrenal izquierda. Siendo los marcadores tumorales negativos en sangre, se realiza una biopsia de la adenopatía supraclavicular con diagnóstico de M+ ganglionar por carcinoma embrionario de probable origen testicular. Posteriormente se realiza ecografía testicular observándose nódulo hipoecoico en teste derecho de 6mm, realizándose orquiectomía derecha cuyo estudio histopatológico revela un tumor sólido de 1cm histologicamente tipificable como seminoma clásico con extensión pagetoide a rete testes, la albugínea y el cordón espermático estaban libres de infiltración. Actualmente el paciente esta en tratamiento quimioterápico (2º ciclo del esquema BEP -bleomicina, etopósido, y cisplatino-). Conclusiones: El interés del caso es tanto por la presentación clínica agresiva inhabitual del este tumor así como por la revisión bibliográfica donde se abordan las posibles teorías del porque los tumores de células germinales testiculares suelen presentar diversos tipos de diferenciación así como por la posible regresión espontánea de los mismos (AU)


Objectives: The existence of non seminomatous mixed germ cell tumors of the testis is a frequent event in urologic oncology. Nevertheless, the presence of both components, seminomatous and non seminomatous, in a germ cell tumor is unusual. Methods: We present a case of pure classic seminoma of the testis with a lymph node metastasis of pure embryonal carcinoma, with confirmatory immuohistochemical study and clinical outcome of the patient. Results: A 34 year old man presented with 3 cm supraclavicular tumor. CT scan also revealed multiple metastases in lymph nodes, liver, kidney and left adrenal gland. Tumor markers were negative and the biopsy performed discovered a lymph node metastasis of embryonal carcinoma of probable testicular origin. Ultrasound revealed a 6 mm hypoechoic nodule in the right testis. Orchyectomy was performed and pathologic analysis demonstrated a tumor, 1 cm of diameter, histopathologically compatible with classical seminoma with pagetoid extension to rete testis. Albuginea and spermatic cord did not present neoplastic involvement. Currently the patient is being treated with chemotherapy. Conclusion: The interest of the case is to remark an unusual aggressive clinical presentation as well as to perform a bibliographic review with emphasis in the theories regarding heterogeneous differentiation and spontaneous regression of germ cell tumors of the testis (AU)


Subject(s)
Humans , Male , Adult , Germinoma/complications , Germinoma/diagnosis , Germinoma/surgery , Seminoma/complications , Immunohistochemistry/methods , Tomography, Emission-Computed/methods , Orchiectomy/methods , Diagnosis, Differential , Germinoma/physiopathology , Germinoma , Biomarkers , Testis/pathology , Testis
14.
J Neurooncol ; 88(3): 309-14, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18365143

ABSTRACT

Among intracranial germinomas, basal ganglia germinomas represent a specific clinical and anatomical entity. Based on an unusual case of a basal ganglia germinoma in a 13-year-old Caucasian male, we highlight the diagnostic challenges and discuss treatment considerations in this disease.


Subject(s)
Basal Ganglia Diseases/diagnosis , Basal Ganglia Diseases/therapy , Brain Neoplasms/diagnosis , Brain Neoplasms/therapy , Germinoma/diagnosis , Germinoma/therapy , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Basal Ganglia Diseases/physiopathology , Brain Neoplasms/physiopathology , Cranial Irradiation , Germinoma/physiopathology , Humans , Magnetic Resonance Imaging , Male , Tomography, X-Ray Computed
16.
Childs Nerv Syst ; 23(1): 105-8, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17058090

ABSTRACT

CASE REPORT: The authors describe a unique case of an 8-year-old girl with a germinoma located in the left basal ganglia. Medical history begins 5 months before with a central diabetes insipidus, loss of weight (5 kg at admission), vomiting and asthenia. Computed tomography (CT) and cranial magnetic resonance imaging (MRI) are performed and demonstrate a left basal ganglia tumour (nucleus lentiformis). Diabetes insipidus is considered as non-visible germinoma localization on the pituitary stalk rather than as a possible consequence of peri-tumoural oedema surrounding the hypothalamus. Spinal MRI is normal. Neurological as well as general examination is normal. DISCUSSION: The first hypothesis is low-grade glioma, but pathological examination following a stereotactic biopsy of the lesion reveals a cerebral germinoma. A few days before the biopsy, the girl experienced a mild left facial palsy, and CT scans at the time of biopsy reveals an intra-tumoural haemorrhage. Alpha fetoprotein and human chorionic gonadotrophin were negative as blood and cerebrospinal fluid markers, whereas placental alkaline phosphatase was positive on immunohistochemical profile of the tumour samples. Dedicated chemotherapy, followed by focal irradiation (40 Gy, 30 sessions, 45 days; SIOP CNS GCT 93 protocol), is performed with a complete response. The outcome is good (Glasgow Outcome Scale=I), without any cognitive impairment and the persistence of a mild facial palsy and a slight right arm dystonia on last neurological examination. There is still no evidence of tumour recurrence.


Subject(s)
Basal Ganglia/pathology , Brain Neoplasms/pathology , Brain Neoplasms/physiopathology , Germinoma/pathology , Germinoma/physiopathology , Antineoplastic Agents/therapeutic use , Asthenia/etiology , Basal Ganglia/metabolism , Brain Neoplasms/therapy , Child , Combined Modality Therapy , Diabetes Insipidus/etiology , Diagnosis, Differential , Female , Germinoma/therapy , Glioma/pathology , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Radiotherapy , Tomography, X-Ray Computed , Vomiting/etiology , Weight Loss
17.
Neurosurgery ; 59(2): 267-77; discussion 267-77, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16883167

ABSTRACT

OBJECTIVE: Evaluation of results of the neurofiberscopic biopsy of tumors of the pineal region and posterior third ventricle. METHODS: From 2001 to 2004, 23 patients (mean age, 30.6 yr) with tumors located in the pineal region or posterior third ventricle underwent neurofiberscopic biopsy with simultaneous third ventriculostomy. The procedure was indicated for verification of the histological diagnosis of the neoplasm, which was planned to be treated by radiotherapy and/or chemotherapy without open surgery (eight patients), establishment of the pathological diagnosis for further choice of the most appropriate treatment strategy (11 patients), differentiation of the recurrent neoplasm and radiation necrosis (two patients), and decompression of the large tumor-associated cyst (two patients). In six previously shunted patients, substitution of the ventriculoperitoneal shunt on the third ventricle stoma was performed. RESULTS: There was no postoperative mortality or permanent morbidity. In all cases, the obtained tissue sample was sufficient for pathological diagnosis. Transient postoperative complications included fever (15 patients), nausea and vomiting (three patients), and diplopia (one patient). On the long-term follow-up, delayed third ventricular stoma failure caused by tumor regrowth and scar formation was found in one patient, and dissemination of the malignant glioma through the subarachnoid space was found in another patient. CONCLUSION: Neurofiberscopic biopsy represents a useful method for sampling of tumors of the pineal region and posterior third ventricle, which can be effectively used in both previously shunted and shunt-free patients.


Subject(s)
Brain Neoplasms/diagnosis , Endoscopy/methods , Pineal Gland/pathology , Pinealoma/diagnosis , Third Ventricle/pathology , Adolescent , Adult , Aged , Biopsy/adverse effects , Biopsy/instrumentation , Biopsy/methods , Brain Neoplasms/physiopathology , Brain Neoplasms/therapy , Endoscopy/adverse effects , Endoscopy/standards , Female , Fever/etiology , Fever/physiopathology , Fiber Optic Technology/instrumentation , Fiber Optic Technology/methods , Fiber Optic Technology/standards , Germinoma/diagnosis , Germinoma/physiopathology , Germinoma/therapy , Glioma/diagnosis , Glioma/physiopathology , Glioma/therapy , Humans , Intraoperative Complications/etiology , Intraoperative Complications/physiopathology , Intraoperative Complications/prevention & control , Male , Middle Aged , Neoplasm Recurrence, Local , Pineal Gland/physiopathology , Pineal Gland/surgery , Pinealoma/physiopathology , Pinealoma/therapy , Postoperative Complications/etiology , Postoperative Complications/physiopathology , Postoperative Complications/prevention & control , Predictive Value of Tests , Third Ventricle/physiopathology , Third Ventricle/surgery , Ventriculoperitoneal Shunt , Ventriculostomy/instrumentation , Ventriculostomy/methods
20.
Acta Neurochir (Wien) ; 148(5): 499-509; discussion 509, 2006 May.
Article in English | MEDLINE | ID: mdl-16374568

ABSTRACT

Brain stem mapping (BSM) is an intraoperative neurophysiological procedure to localize cranial motor nuclei on the floor of the fourth ventricle. BSM enables neurosurgeon to understand functional anatomy on the distorted floor of the fourth ventricle, thus, it is emerging as an indispensable tool for challenging brain stem surgery. The authors described the detail of BSM with the special emphasis on its clinical application for the brain stem lesion. Surgical implications based on the result of brains stem mapping would be also informative before planning a brain stem surgery through the floor of fourth ventricle. Despite the recent advancement of MRI to depict the lesion in the brain stem, BSM remains as the only way to provide surgical anatomy in the operative field. BSM could guide a neurosurgeon to the inside of brain stem while preventing direct damage to the cranial motor nuclei on the floor of the fourth ventricle. It is expected that understanding its advantage and limitations would help neurosurgeon to perform safer surgery to the brain stem lesion.


Subject(s)
Brain Mapping , Brain Stem Neoplasms/surgery , Brain Stem/physiopathology , Ependymoma/surgery , Germinoma/surgery , Hemangioma/surgery , Adult , Brain Stem Neoplasms/pathology , Brain Stem Neoplasms/physiopathology , Child, Preschool , Ependymoma/pathology , Ependymoma/physiopathology , Female , Germinoma/pathology , Germinoma/physiopathology , Hemangioma/pathology , Hemangioma/physiopathology , Humans , Monitoring, Intraoperative
SELECTION OF CITATIONS
SEARCH DETAIL
...